Parkinson Disease Clinical Trials in Irvine, California

4 studies are recruiting for parkinson disease in Irvine, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

    A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Site-003, Irvine, California
    Locations
    22 in total
    Run by
    Biohaven Therapeutics Ltd.

    See if you can join NCT06976268 on ClinicalTrials.gov

  2. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    University of California, Irvine, Irvine, California
    Locations
    72 in total
    Run by
    Neuron23 Inc.

    See if you can join NCT06680830 on ClinicalTrials.gov

  3. A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

    The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

    Stage
    Phase 2
    Ages
    45 to 75
    Site
    UCI Alpha Clinic (Neurology), Irvine, California
    Locations
    46 in total
    Run by
    AskBio Inc

    See if you can join NCT06285643 on ClinicalTrials.gov

  4. Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

    Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease

    Stage
    Not phased
    Ages
    18 and older
    Site
    Parkinson's Disease and Movement Disorders Center - Orange County (North), Irvine, California
    Locations
    5 in total
    Run by
    Supernus Pharmaceuticals, Inc.

    See if you can join NCT07219927 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.